Mice continue to be a good model for preliminary assessment of tuberculosis vaccine candidates.
作者信息
Aceves-Sánchez Michel de Jesús, Flores-Valdez Mario Alberto
机构信息
a Biotecnología Médica y Farmacéutica , Centro de Investigación y Asistencia en Tecnología y Diseño del Estado de Jalisco , A.C., Guadalajara , Jalisco , México.
出版信息
Hum Vaccin Immunother. 2017 Mar 4;13(3):634-635. doi: 10.1080/21645515.2016.1248010. Epub 2016 Oct 20.
Abstract
摘要
相似文献
1
Mice continue to be a good model for preliminary assessment of tuberculosis vaccine candidates.
Hum Vaccin Immunother. 2017 Mar 4;13(3):634-635. doi: 10.1080/21645515.2016.1248010. Epub 2016 Oct 20.
2
Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design.
Infect Immun. 2018 Jan 22;86(2). doi: 10.1128/IAI.00776-17. Print 2018 Feb.
3
Vaccines against tuberculosis: moving forward with new concepts.
Expert Rev Vaccines. 2013 Aug;12(8):829-31. doi: 10.1586/14760584.2013.814836. Epub 2013 Aug 14.
4
A novel multivalent tuberculosis vaccine confers protection in a mouse model of tuberculosis.
Hum Vaccin Immunother. 2016 Oct 2;12(10):2649-2653. doi: 10.1080/21645515.2016.1197454. Epub 2016 Jun 20.
5
Complement component 3: a new paradigm in tuberculosis vaccine.
Expert Rev Vaccines. 2016;15(3):275-7. doi: 10.1586/14760584.2016.1125294. Epub 2015 Dec 15.
6
Tuberculosis vaccines: barriers and prospects on the quest for a transformative tool.
Immunol Rev. 2015 Mar;264(1):363-81. doi: 10.1111/imr.12270.
7
An adult zebrafish model for preclinical tuberculosis vaccine development.
Vaccine. 2013 Oct 25;31(45):5202-9. doi: 10.1016/j.vaccine.2013.08.093. Epub 2013 Sep 20.
8
Vaccination Against Tuberculosis With Whole-Cell Mycobacterial Vaccines.
J Infect Dis. 2016 Sep 1;214(5):659-64. doi: 10.1093/infdis/jiw228. Epub 2016 May 30.
9
Recent developments in tuberculosis vaccines.
Expert Rev Vaccines. 2013 Dec;12(12):1431-48. doi: 10.1586/14760584.2013.856765.
10
Fact and fiction in tuberculosis vaccine research: 10 years later.
Lancet Infect Dis. 2011 Aug;11(8):633-40. doi: 10.1016/S1473-3099(11)70146-3.
引用本文的文献
1
Efficacy and immunogenicity of different BCG doses in BALB/c and CB6F1 mice when challenged with H37Rv or Beijing HN878.
Sci Rep. 2021 Dec 2;11(1):23308. doi: 10.1038/s41598-021-02442-5.
本文引用的文献
1
Tuberculosis Susceptibility and Vaccine Protection Are Independently Controlled by Host Genotype.
mBio. 2016 Sep 20;7(5):e01516-16. doi: 10.1128/mBio.01516-16.
2
A Mouse Model of Latent Tuberculosis Infection to Study Intervention Strategies to Prevent Reactivation.
PLoS One. 2016 Jul 8;11(7):e0158849. doi: 10.1371/journal.pone.0158849. eCollection 2016.
3
Prophylactic Use of Ganoderma lucidum Extract May Inhibit Mycobacterium tuberculosis Replication in a New Mouse Model of Spontaneous Latent Tuberculosis Infection.
Front Microbiol. 2016 Jan 8;6:1490. doi: 10.3389/fmicb.2015.01490. eCollection 2015.
4
Mouse models of human TB pathology: roles in the analysis of necrosis and the development of host-directed therapies.
Semin Immunopathol. 2016 Mar;38(2):221-37. doi: 10.1007/s00281-015-0538-9. Epub 2015 Nov 5.
5
Large animal models for vaccine development and testing.
ILAR J. 2015;56(1):53-62. doi: 10.1093/ilar/ilv009.
6
PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice.
Int J Antimicrob Agents. 2014 Dec;44(6):564-6. doi: 10.1016/j.ijantimicag.2014.07.012. Epub 2014 Sep 16.
7
A humanized mouse model of tuberculosis.
PLoS One. 2013 May 17;8(5):e63331. doi: 10.1371/journal.pone.0063331. Print 2013.
8
Animal models of tuberculosis for vaccine development.
Indian J Med Res. 2009 Jan;129(1):11-8.
9
Mouse and guinea pig models for testing new tuberculosis vaccines.
Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):13-7. doi: 10.1016/j.tube.2004.08.001. Epub 2005 Jan 22.
10
Disease model: pulmonary tuberculosis.
Trends Mol Med. 2001 Mar;7(3):135-7. doi: 10.1016/s1471-4914(00)01901-8.
Zotero 插件